You just read:

OncoSec to Present New Clinical Data from Phase 2 Combination Study at ASCO-SITC Clinical Immuno-Oncology Symposium and Corporate Updates at Two Investment Conferences in February

News provided by

OncoSec Medical Incorporated

Feb 08, 2017, 06:01 ET